Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MACK | CLLS | NVCT | ||
| Company | Merrimack Pharmaceuticals Inc | Cellectis S.A. ADR | Nuvectis Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 15.15 | 4.10 | 8.50 | ||
| High | 15.17 | 4.14 | 8.76 | ||
| Low | 15.13 | 3.93 | 8.44 | ||
| Latest | 15.13 | 4.07 | 8.48 | ||
| Change | unch | -0.01 | -0.05 | ||
| % Change | unch | -0.37% | -0.59% | ||
| Volume | 1,255,700 | 72,800 | 57,800 | ||
| 20-Day Average Volume | 396,880 | 81,150 | 85,530 | ||
| Previous Close | 15.13 | 4.09 | 8.53 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.95 | 4.52 | 8.15 | ||
| 20-Day Raw Stochastic | 92.47% | 11.97% | 56.76% | ||
| 20-Day Relative Strength | 74.45 | 44.07 | 60.26 | ||
| Weighted Alpha | +23.43 | +129.31 | +45.62 | ||
| Today's Opinion | 100% Buy | 64% Buy | 72% Buy | ||
| Previous Opinion | 100% Buy | 64% Buy | 72% Buy | ||
| Last Month's Opinion | 80% Buy | 64% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.07% since 05/10/24 | -7.71% since 01/09/26 | +0.24% since 01/09/26 | ||
| Low | 15.10 on 05/13/24 | 3.93 on 01/16/26 | 7.95 on 01/12/26 | ||
| High | 15.16 on 05/17/24 | 4.39 on 01/12/26 | 8.76 on 01/16/26 | ||
| 1-Month | |||||
| %Chg | +3.07% since 04/17/24 | +0.25% since 12/16/25 | +10.27% since 12/16/25 | ||
| Low | 14.67 on 04/18/24 | 3.91 on 12/17/25 | 7.22 on 12/31/25 | ||
| High | 15.16 on 05/17/24 | 5.10 on 12/29/25 | 9.44 on 01/08/26 | ||
| 3-Month | |||||
| %Chg | +2.93% since 02/16/24 | -9.96% since 10/16/25 | +39.24% since 10/16/25 | ||
| Low | 14.60 on 03/12/24 | 3.12 on 11/06/25 | 5.55 on 11/07/25 | ||
| High | 15.16 on 05/17/24 | 5.45 on 12/11/25 | 9.44 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | +18.02% since 11/17/23 | +104.52% since 07/16/25 | +3.79% since 07/16/25 | ||
| Low | 12.54 on 11/30/23 | 1.77 on 07/21/25 | 5.55 on 11/07/25 | ||
| High | 15.89 on 02/13/24 | 5.48 on 10/16/25 | 9.44 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 223,742 | 226,211 | 217,215 | ||
| Shares Outstanding, K | 14,788 | 55,580 | 25,615 | ||
| Annual Sales | 0 | 49,220,000 | 0 | ||
| Annual Net Income | -1,180,000 | -36,760,000 | -19,000,000 | ||
| Last Quarter Sales | 0 | 37,160,000 | 0 | ||
| Last Quarter Net Income | -240,000 | 590,000 | -7,460,000 | ||
| 60-Month Beta | 1.45 | 2.82 | -0.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 05/15/24 | 0.01 on 11/07/25 | -0.44 on 11/04/25 | ||
| Latest Earnings Date | 08/01/24 | 03/12/26 | 02/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | 05/30/17 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||